Squarepoint Ops LLC Regenxbio Inc. Transaction History

Squarepoint Ops LLC

$57 Billion
Q1 2024

A detailed history of Squarepoint Ops LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 20,010 shares of RGNX stock, worth $218,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,010

Holding current value

$218,109

% of portfolio

0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.17 - $24.61 $243,521 - $492,446	20,010 New	20,010 $421,000
Q4 2021 Feb 14, 2022	SELL	$30.19 - $40.28 $1.44 Million - $1.92 Million	-47,605 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $595,268 - $934,749	20,463 Added 75.39%	47,605 $2 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $155,028 - $193,332	4,776 Added 21.35%	27,142 $1.05 Million
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $172,318 - $256,093	5,127 Added 29.74%	22,366 $763,000

Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $751,629 - $1.4 Million	-28,342 Reduced 62.18%	17,239 $782,000
Q3 2020 Nov 16, 2020	BUY	$27.01 - $40.26 $578,689 - $862,570	21,425 Added 88.69%	45,581 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $406,815 - $636,830	14,660 Added 154.38%	24,156 $890,000
Q1 2020 May 15, 2020	SELL	$21.5 - $54.2 $719,906 - $1.81 Million	-33,484 Reduced 77.91%	9,496 $307,000
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $278,219 - $361,427	8,055 Added 23.06%	42,980 $1.76 Million
Q3 2019 Nov 14, 2019	BUY	$31.84 - $50.88 $1.11 Million - $1.78 Million	34,925 New	34,925 $1.24 Million
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $2.54 Million - $3.59 Million	-60,537 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $1.31 Million - $2.01 Million	32,192 Added 113.57%	60,537 $3.47 Million
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $1.11 Million - $2.13 Million	28,345 New	28,345 $1.19 Million
Q3 2018 Nov 14, 2018	SELL	$65.0 - $82.15 $437,125 - $552,458	-6,725 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$27.2 - $74.35 $527,244 - $1.44 Million	-19,384 Reduced 74.24%	6,725 $483,000
Q1 2018 May 15, 2018	SELL	$24.05 - $37.5 $223,953 - $349,200	-9,312 Reduced 26.29%	26,109 $779,000
Q4 2017 Feb 14, 2018	BUY	$26.0 - $34.6 $920,946 - $1.23 Million	35,421	35,421 $1.18 Million

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

42.1M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $471M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account